SCHEMBL17248402

SCHEMBL17248402

c1cc(-c2ccc3c(c2)c2ccccc2n3-c2ccc3c(c2)sc2ccccc23)cc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 3/20 0.39
RAB9A P51151 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GPR3 P46089 1/20 0.37
TSPO P30536 1/20 0.33
PIM3 Q86V86 1/20 0.32
ALOX5 P09917 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
HSD17B10 Q99714 1/20 0.31
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31
HDAC4 P56524 1/20 0.30
KMT2A Q03164 1/20 0.30
IL1R1 P14778 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20391971 0.97 ATM (0.41) KDM4EATML3MBTL1MAPTRAB9A
SCHEMBL21481442 0.97 ATM (0.41) KDM4EATML3MBTL1MAPTRAB9A
SCHEMBL25941275 0.97 ATM (0.41) KDM4EATML3MBTL1MAPTRAB9A
SCHEMBL22174965 0.96 ATM (0.41) KDM4EATML3MBTL1MAPTRAB9A
SCHEMBL22174884 0.95 ATM (0.40) KDM4EATML3MBTL1MAPTRAB9A
SCHEMBL19009384 0.95 ATM (0.40) KDM4EATML3MBTL1MAPTRAB9A
SCHEMBL19009385 0.95 ATM (0.40) KDM4EATML3MBTL1MAPTRAB9A
SCHEMBL25941127 0.95 ATM (0.40) KDM4EATML3MBTL1MAPTRAB9A
SCHEMBL23468730 0.95 ALDH1A1 (0.42) KDM4EATML3MBTL1MAPTRAB9A
SCHEMBL22671758 0.94 L3MBTL1 (0.37) KDM4EATML3MBTL1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220216427-A1 ORGANIC ELECTROLUMINESCENT ELEMENT NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2022-07-07 US disclosed
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 KDM4E 1228/4885ATM 3768/4885L3MBTL1 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.